Skip to main content
SpringerLink
Log in

Cervix Cancer

  • Book
  • © 1987

Overview

Editors:
  1. Earl A. Surwit

    1. Gynecologic Oncology, Tucson, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. David S. Alberts

    1. Section of Hematology and Oncology, Department of Internal Medicine 6th Floor Facility, Arizona Health Sciences Center, University of Arizona, Tucson, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Cancer Treatment and Research (CTAR, volume 31)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Front Matter

    Pages I-XVI
    Download chapter PDF

  2. Cervical dysplasia

    • Sheldon A. Weiner
    Pages 1-10

  3. The management of the high risk patient with early invasive carcinoma of the cervix

    • Kjell E. Kjorstad
    Pages 11-31

  4. Cytosolic estrogen and progesterone receptors in primary cervical carcinoma

    • Leo B. Twiggs, Roger A. Potish, Benjamin S. Leung
    Pages 33-41

  5. Surgical staging of cervical cancer

    • Neville F. Hacker, Jonathan S. Berek
    Pages 43-57

  6. Pre-operative radiotherapy for carcinoma of the cervix

    • Nina Einhorn
    Pages 59-65

  7. Radical hysterectomy and pelvic lymphadenectomy

    • Karl C. Podratz, Richard E. Symmonds
    Pages 67-88

  8. Treatment of locally advanced cancer of the cervix with interstitial parametrial implants

    • Silvio A. Aristizabal
    Pages 89-106

  9. Hydroxyurea and radiation therapy in the treatment of carcinoma of the cervix

    • M. Steven Piver
    Pages 107-118

  10. Single agent chemotherapy in carcinoma of the cervix

    • J. Tate Thigpen
    Pages 119-136

  11. Combination chemotherapy of advanced cervix cancer

    • Dean E. Brenner
    Pages 137-160

  12. Primary chemotherapy for high-risk recurrence cervix cancer

    • David S. Alberts, Silvio Aristizabal, Earl A. Surwit, Sheldon Weiner
    Pages 161-183

  13. Human tumor clonogenic assay studies of cervical cancer

    • Charles E. Welander, R. Lamar Parker Jr.
    Pages 185-197

  14. Back Matter

    Pages 199-207
    Download chapter PDF
Back to top

Keywords

About this book

Cytological screening for the identification of intraepithelial neoplasia of the cervix as a precursor lesion for cervical cancer has been well established as an effective means for decreasing the incidence of invasive carcinoma. Despite these screening efforts, carcinoma of the cervix remains one of the more common malignancies in women and it is the leading cause of cancer death in many countries in the western hemisphere. It is estimated that in 1986 there will still be 14,000 new cases of invasive cancer, with 6,800 deaths in the United States alone. Unfortunately, many of these patients present with advanced disease, posing difficult management problems for the clinician responsible for their care. The treatment of early stage invasive carcinoma of the cervix (lesions confined to the cervix and vagina) remains either radical surgery, radical radiation therapy or a combination thereof This approach is extraordinarily effective in the vast majority of patients. However, there remains a subset of patients with early stage disease that are at high risk for recurrence. Dr Kjorstad (Chapter 2) has identified adenocarcinomas and adenosqua­ mous carcinomas as having a particularly poor prognosis. In addition, patients with more than three positive lymph nodes or with involvement of lymph nodes outside of the pelvis have a very poor prognosis. He has iden­ tified the CEA as a potentially predictive marker for these patients with poor prognosis, especially in patients with adenocarcinomas.

Editors and Affiliations

  • Gynecologic Oncology, Tucson, USA

    Earl A. Surwit

  • Section of Hematology and Oncology, Department of Internal Medicine 6th Floor Facility, Arizona Health Sciences Center, University of Arizona, Tucson, USA

    David S. Alberts

Bibliographic Information

  • Book Title: Cervix Cancer

  • Editors: Earl A. Surwit, David S. Alberts

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-1-4613-2027-2

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Martinus Nijhoff Publishers, Boston 1987

  • Hardcover ISBN: 978-0-89838-822-0Published: 31 March 1987

  • Softcover ISBN: 978-1-4612-9207-4Published: 15 September 2011

  • eBook ISBN: 978-1-4613-2027-2Published: 06 December 2012

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: XVI, 208

  • Topics: Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation